MedPath

MAVENCLAD

MAVENCLAD

Approved
DIN Number

02470179

Drug Class

Human

Market Date

Nov 30, 2017

Company
HC

emd serono, a division of emd inc., canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02470179
AIG Number0124270002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AA40* CLADRIBINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification90:04.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

CLADRIBINEActive
Strength: 10 MG
Monograph: CLADRIBINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.